ICIG buys Roche’s pharmaceutical manufacturing facility in Boulder

ICIG buys Roche’s pharmaceutical manufacturing facility in Boulder

2:24 PM, 10th August 2011
ICIG buys Roche’s pharmaceutical manufacturing facility in Boulder
Roche’s pharmaceutical production facility in Boulder, Colorado.

BOULDER, US: The Roche Group and International Chemical Investors Group (ICIG) agreed for ICIG to acquire Roche Colorado Corporation, which includes Roche’s pharmaceutical production facility in Boulder, Colorado. As per the agreement, ICIG will acquire the Roche affiliate company in Boulder with its technical development and small molecule manufacturing capabilities. Roche Colorado currently has a workforce of approximately 265 employees.

ICIG intends to operate the Boulder site, renamed “Corden Pharma Colorado Inc,” as part of its pharmaceutical business. Corden Pharma is the pharmaceutical arm of ICIG investments. Also Corden Pharma Colorado will supply Roche with a number of active pharmaceutical ingredients (API) that the Boulder site produces.  

“Selling the Boulder site to ICIG will secure a reliable supplier to meet Roche’s demand for commercial scale peptides and other medicinal compounds,” said Dr Georg Wiebecke, Head of Chemical Manufacturing, Roche.   

Roche’s Boulder facility produces therapeutic peptide compounds, having pioneered large scale synthetic manufacturing technologies. The Boulder site is also capable of producing complex small molecules and highly potent compounds.

“With this purchase, we form a commanding presence in contract peptide manufacturing industry,” said Dr Wolfgang Niedermaier, President, Corden Pharma.  “This will help us to expand the market for Boulder site’s unique technical capabilities, attracting additional API production opportunities that will build on its existing portfolio of Roche products.”

© WOC News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Researchers use neutrons to spy on the elusive hydronium ion

LOS ALAMOS, NEW MEXICO: A Los Alamos National Laboratory research team has harnessed neutrons to view for the first time the critical role that an elu ...

Read more
China resorts to massive crackdown on food safety concerns

  BEIJING, CHINA: The Chinese authorities has arrested around 2,000 people and closed nearly 5,000 businesses in a major crackdown on illegal fo ...

Read more
Solazyme, Bunge form JV for commercial renewable oil plant in Brazil

  SAN FRANCISCO, US: Solazyme Inc and Bunge Global Innovation LLC, a wholly-owned subsidiary of Bunge Limited have entered into a framework agre ...

Read more
DKSH to distribute Tonsan’s products for photovoltaic market in Europe

  ZURICH, SWITZERLAND: DKSH and Beijing-based Tonsan Adhesives Co Ltd, have agreed to expand their strategic partnership with a new agreement fo ...

Read more
SOCAR invites bids for nitrogen fertilizer plant in Azerbaijan

  BAKU, AZERBAIJAN: The state oil company of Azerbaijan, SOCAR has invited bids, a procedure for the turnkey construction of a plant for product ...

Read more
Jayant Agro buys Mitsui stake in Ihsedu Speciality Chemicals

MUMBAI, INDIA: Jayant Agro Organics Ltd has acquired the 24 per cent paid-up share capital held by Mitsui Group in Ihsedu Speciality Chemicals Pvt Ltd ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X